跳至主要内容
临床试验/JPRN-UMIN000049741
JPRN-UMIN000049741招募中Unknown

The effect of romosozumab and denosumab on bone mineral density in patients with rheumatoid arthritis - The effect of romosozumab and denosumab on bone mineral density in patients with rheumatoid arthritis

Tokyo Metropolitan Tama medical center0 个研究点目标入组 70 人开始时间: 2022年12月10日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
70

研究概览

简要总结

Patients were enrolled to 26 cases in romosozumab group and 24 cases in denosumab group. Data were input to excel and are going to be analyzed.

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 95years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who are not diagnosed with rheumatoid arthritis or osteoporosis. 2. Patients with a history of ischemic heart disease or cerebrovascular disease within the past 1 year are excluded from the romosozumab group. 3.Patients who are allergic to romosozumab or denosumab. 4.Patients who are judged to be unsuitable as subjects by the principal investigator.

研究者

相似试验